Combining to accelerate PBM industry transformation and revolutionize the broader healthcare experience
SAN JUAN, Puerto Rico, August 20, 2026
LucyRx and Abarca Health today announced the completion of their previously announced strategic combination.
Together, LucyRx and Abarca serve more than 9 million members across commercial and government markets. The completed combination brings together LucyRx’s employer-market expertise, clinical capabilities, and high-touch service model with Darwin, a modern, integrated claims and benefits platform proven at scale, and Abarca’s deep expertise in health plans, regulatory compliance, and government programs.
LucyRx and Abarca now operate as wholly owned subsidiaries of Healthcare Revolution Partners. Both companies continue to operate independently through their established brands, leadership teams, systems, and client relationships. Clients and members will experience no disruption as day-to-day execution continues with the same teams, standards, responsiveness, and account relationships.
Together, LucyRx and Abarca have greater scale, technology, and specialized expertise to support larger and more complex organizations across employer, public-sector, health plan, and government program markets while preserving the relationships, accountability, and service clients value.
For more information, visit acceleratetherevolution.com.

__
About Abarca Health
At Abarca Health, we believe in an Unstoppable Drive for a Better Way. We combine innovative technology and healthcare expertise to make pharmacy benefit management more seamless and personalized. From AI and predictive analytics to specialty pharmacy solutions, we transform complex challenges into opportunities and deliver PBM like no one else.
Following the strategic combination with LucyRx, Abarca now operates as a wholly owned subsidiary of Healthcare Revolution Partners, strengthening its scale and capabilities across commercial and government markets.
Discover how Abarca is helping shape a better future for healthcare.
Last Updated on October 14, 2026